Kumar Dilip Ashtekar

839 total citations
18 papers, 568 citations indexed

About

Kumar Dilip Ashtekar is a scholar working on Organic Chemistry, Inorganic Chemistry and Molecular Biology. According to data from OpenAlex, Kumar Dilip Ashtekar has authored 18 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 6 papers in Inorganic Chemistry and 3 papers in Molecular Biology. Recurrent topics in Kumar Dilip Ashtekar's work include Oxidative Organic Chemistry Reactions (7 papers), Vanadium and Halogenation Chemistry (6 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Kumar Dilip Ashtekar is often cited by papers focused on Oxidative Organic Chemistry Reactions (7 papers), Vanadium and Halogenation Chemistry (6 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Kumar Dilip Ashtekar collaborates with scholars based in United States and Japan. Kumar Dilip Ashtekar's co-authors include Babak Borhan, James E. Jackson, Roozbeh Yousefi, Richard J. Staples, Hadi Gholami, Mercy Anyika, Daniel C. Whitehead, Daniel Holmes, Arvind Jaganathan and Mathew J. Vetticatt and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Kumar Dilip Ashtekar

18 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumar Dilip Ashtekar United States 11 406 213 86 78 47 18 568
Yu Fan China 11 671 1.7× 204 1.0× 36 0.4× 182 2.3× 25 0.5× 29 811
Guillaume Prestat France 25 1.4k 3.4× 238 1.1× 37 0.4× 228 2.9× 40 0.9× 72 1.5k
Shuji Masumoto Japan 13 626 1.5× 246 1.2× 23 0.3× 177 2.3× 76 1.6× 19 754
Candice Botuha France 17 817 2.0× 173 0.8× 35 0.4× 224 2.9× 62 1.3× 40 921
Ashraf Wilsily Canada 13 875 2.2× 295 1.4× 38 0.4× 127 1.6× 13 0.3× 17 961
Aaron C. Burns United States 13 576 1.4× 108 0.5× 19 0.2× 154 2.0× 16 0.3× 17 761
Yi Xiang China 8 551 1.4× 125 0.6× 78 0.9× 247 3.2× 20 0.4× 13 742
Jinlong Zhang China 15 465 1.1× 81 0.4× 77 0.9× 127 1.6× 52 1.1× 35 684
Jorma Hassfeld Germany 17 553 1.4× 154 0.7× 81 0.9× 264 3.4× 46 1.0× 31 779

Countries citing papers authored by Kumar Dilip Ashtekar

Since Specialization
Citations

This map shows the geographic impact of Kumar Dilip Ashtekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumar Dilip Ashtekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumar Dilip Ashtekar more than expected).

Fields of papers citing papers by Kumar Dilip Ashtekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumar Dilip Ashtekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumar Dilip Ashtekar. The network helps show where Kumar Dilip Ashtekar may publish in the future.

Co-authorship network of co-authors of Kumar Dilip Ashtekar

This figure shows the co-authorship network connecting the top 25 collaborators of Kumar Dilip Ashtekar. A scholar is included among the top collaborators of Kumar Dilip Ashtekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumar Dilip Ashtekar. Kumar Dilip Ashtekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Petrova, Zaritza O., et al.. (2024). A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition. npj Precision Oncology. 8(1). 3–3. 3 indexed citations
2.
Li, Zheng, Hadi Gholami, Kumar Dilip Ashtekar, et al.. (2023). Structure Guided Design of VANOL-Imidodiphosphorimidate Catalysts for the Catalytic Enantioselective Bromospiroketalization Reaction. ACS Catalysis. 14(1). 426–436. 7 indexed citations
3.
Sausville, Erin L., et al.. (2023). Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor. Cell chemical biology. 30(10). 1211–1222.e5. 9 indexed citations
4.
Petrova, Zaritza O., Anatoly Kiyatkin, Chun Hu, et al.. (2023). Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes. Cell Reports. 43(1). 113603–113603. 10 indexed citations
6.
Lu, David, Michael J. Grant, Steven E. Stayrook, et al.. (2022). Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations. Nature Communications. 13(1). 6791–6791. 17 indexed citations
7.
Ashtekar, Kumar Dilip, Hadi Gholami, Mehdi Moemeni, et al.. (2021). A Mechanistically Inspired Halenium Ion Initiated Spiroketalization: Entry to Mono‐ and Dibromospiroketals. Angewandte Chemie International Edition. 61(8). e202115173–e202115173. 3 indexed citations
8.
Yousefi, Roozbeh, Aritra Sarkar, Kumar Dilip Ashtekar, et al.. (2020). Mechanistic Insights into the Origin of Stereoselectivity in an Asymmetric Chlorolactonization Catalyzed by (DHQD)2PHAL. Journal of the American Chemical Society. 142(15). 7179–7189. 34 indexed citations
9.
Truini, Anna, Jacqueline H. Starrett, Tyler F. Stewart, et al.. (2019). The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma. Clinical Cancer Research. 25(21). 6382–6391. 38 indexed citations
10.
Yousefi, Roozbeh, et al.. (2018). Absolute and relative facial selectivities in organocatalytic asymmetric chlorocyclization reactions. Chemical Science. 9(11). 2898–2908. 22 indexed citations
11.
Ashtekar, Kumar Dilip, Mathew J. Vetticatt, Roozbeh Yousefi, James E. Jackson, & Babak Borhan. (2016). Nucleophile-Assisted Alkene Activation: Olefins Alone Are Often Incompetent. Journal of the American Chemical Society. 138(26). 8114–8119. 75 indexed citations
12.
Ashtekar, Kumar Dilip, Xinliang Ding, Wei Sheng, et al.. (2016). Mechanistically Inspired Route toward Hexahydro-2H-chromenes via Consecutive [4 + 2] Cycloadditions. Organic Letters. 18(16). 3976–3979. 9 indexed citations
13.
Ashtekar, Kumar Dilip, et al.. (2014). A New Tool To Guide Halofunctionalization Reactions: The Halenium Affinity (HalA) Scale. Journal of the American Chemical Society. 136(38). 13355–13362. 73 indexed citations
14.
Yousefi, Roozbeh, Kumar Dilip Ashtekar, Daniel C. Whitehead, James E. Jackson, & Babak Borhan. (2013). Dissecting the Stereocontrol Elements of a Catalytic Asymmetric Chlorolactonization: Syn Addition Obviates Bridging Chloronium. Journal of the American Chemical Society. 135(39). 14524–14527. 64 indexed citations
15.
Anyika, Mercy, et al.. (2013). Point-to-Axial Chirality Transfer—A New Probe for “Sensing” the Absolute Configurations of Monoamines. Journal of the American Chemical Society. 136(2). 550–553. 99 indexed citations
17.
Ashtekar, Kumar Dilip, et al.. (2012). 3,4-Dihydroxypyrrolidines via Modified Tandem Aza-Payne/Hydroamination Pathway. Organic Letters. 14(14). 3592–3595. 10 indexed citations
18.
Ashtekar, Kumar Dilip, Richard J. Staples, & Babak Borhan. (2011). Development of a Formal Catalytic Asymmetric [4 + 2] Addition of Ethyl-2,3-butadienoate with Acyclic Enones. Organic Letters. 13(21). 5732–5735. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026